Following a Constitutional Court ruling, Clicks Group plans to sell its shareholding in Unicorn Pharmaceuticals, enabling new pharmacy license applications.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
Tagged , , ,